Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Extension Study to Evaluate Safety and Efficacy of Mepolizumab in Patients With Hypereosinophilic Syndromes

NCT00097370 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00097370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00097370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Extension Study to Evaluate Safety and Efficacy of Mepolizumab in Patients With Hypereosinophilic Syndromes
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2004
Completion date
September 29, 2010
Enrollment
78 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

hypereosinophilic syndrome